Stephen Joseph Warrillow
Abstract
Treating anaemia in the critically ill with EPO cannot be recommended. Of concern is the possibility of increased incidence of thrombotic complications through EPO therapy. With regard to the non- haematopoietic effects of EPO, more research is needed. (non-author abstract)
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Treating anaemia in the critically ill with EPO cannot be recommended. Of concern is the possibility of increased incidence of thrombotic complications through EPO therapy. With regard to the non- haematopoietic effects of EPO, more research is needed. (non-author abstract)
Key concepts: Medicine, Critically ill, Intensive care medicine, Erythropoietin, Current (fluid), Internal medicine, Engineering, Electrical engineering